Zenas BioPharma Announces New Executive Leadership Appointments

Hua Mu, MD, Ph.D. appointed President, CEO and Acting CMO

Joe Farmer appointed CBO

HONG KONG and BOSTON, May 03, 2021 (GLOBE NEWSWIRE) — Zenas BioPharma ("Zenas"), a cross–border (China–USA based) biopharmaceutical company committed to the development and delivery of immune–based therapies, today announced the appointment of Hua Mu, MD, Ph.D. as President and Chief Executive Officer and Acting Chief Medical Officer and Joe Farmer as Chief Business and Administrative Officer.

"We are delighted to have Hua join the Zenas executive leadership team," said Lonnie Moulder, Founder and Executive Chairman. "His extensive experience, including building and leading R&D organizations in China, and his track record of successful development and approval of new drugs in the US and China will be critical as Zenas builds a global organization and advances its innovative pipeline of immune–based therapies."

Dr. Mu joins Zenas after co–founding Overland Pharmaceuticals and serving as Interim Chief Executive Officer and Chief Medical Officer, while also serving as Venture Partner at Hillhouse Capital. Prior to Overland, Dr. Mu served as Chief Scientific Officer and President of R&D and later Chief Medical Officer of Simcere Pharmaceutical Group and President of Simcere of America Inc. Before Simcere, he was Senior Vice President and Global Head of Product Development Service and Partnership at WuXi AppTec. Prior to WuXi, he was Executive Vice President and Chief Medical Officer at Hutchison MediPharma in China. He previously held clinical development executive roles at several global pharmaceutical companies in the US, including Biogen and Genentech.

Dr. Mu received his Ph.D. from the University of California at Berkeley and completed his post–doctorate training at University of California at San Francisco School of Medicine and University of Washington School of Medicine. He received his MD degree from West China University of Medical Sciences.

"Zenas is an innovative biopharmaceutical company uniquely positioned at the nexus of drug development and product flow between China and the West, with an exceptional management team, a world class investor base, and an impressive pipeline of differentiated programs," said Dr. Mu. “I am thrilled to work with the entire Zenas team and network of partners to achieve our mission to transform the lives of patients with unmet medical needs by bringing best–in–class immune–based therapies to the world."

Zenas also announced the appointment of Joe Farmer as Chief Business and Administrative Officer. Mr. Farmer is an accomplished biopharma executive with approximately 25 years of transactional and operational experience working with emerging biotechnology companies at all stages of development, from discovery through commercialization. Prior to joining Zenas, Mr. Farmer served as Chief Operating Officer at Xilio Therapeutics.

Prior to Xilio, Mr. Farmer was the General Counsel and Corporate Secretary at TESARO, where he led the global legal, compliance and government affairs functions and was a key member of the leadership team through its acquisition by GlaxoSmithKline in 2019. He previously served as Chief Corporate Counsel at Cubist Pharmaceuticals through its acquisition by Merck in 2015 and served at other publicly traded companies as General Counsel and Chief Administrative Officer. Mr. Farmer began his career as a corporate attorney at Testa Hurwitz & Thibeault. He received his J.D. from Boston College Law School.

"With the appointments of Hua and Joe, Zenas has further strengthened its executive leadership team," said Lonnie Moulder. "Their respective expertise in building global organizations and executing corporate development strategy through all phases of drug development and commercialization will be invaluable as we continue to advance our global development programs and expand our novel pipeline."

About Zenas BioPharma

Zenas BioPharma is a cross–border (China–USA based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune–based therapies for patients in China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn.

Contacts

Investor Contact:

Zenas BioPharma
IR@zenasbio.com

Media Contact:

Lauren Bartlett
Zenas BioPharma
lauren.bartlett@zenasbio.com


GLOBENEWSWIRE (Distribution ID 8227397)

Josip Heit, GStelecom, G999 and GSmedia, or the questions about the potential of blockchain for private users

HAMBURG, Germany, May 01, 2021 (GLOBE NEWSWIRE) — G999 Blockchain technology, a spam–hacker–free email service, a voice & chat system in compliance with environmental regulations and a current need to manage personal data in a completely secure and risk–free space, away from the mainstream web network through a decentralised data centre and to protect privacy, this innovation was developed by the GSB Blockchain Power Haus in Hamburg.

Against this background, Josip Heit, a proven business manager and blockchain pioneer as well as Chairman of the Board of the GSB Gold Standard Corporate, was interviewed on the topic of blockchain by Deutsche Tageszeitung – Ressort Technik.

Preview of the interview:

Q. Mr Heit, is blockchain or your G999 Blockchain technology https://g999main.net only something for business sectors or can private users also benefit from blockchain?

A. Josip Heit: “Well, at the moment, according to a Deloitte study I have (Deloitte is an international company in the business sector and provides services in the areas of auditing / editor's note), mostly large companies are taking a leading role in the implementation of blockchain technologies, but I am of the opinion that soon medium–sized companies will also be able to participate in the success of the technology and here, in particular, the private user will benefit from the blockchain. “

A PDF of the extended interview can be found here: http://ml.globenewswire.com/Resource/Download/a3dbe5ea–c5e9–411f–a4a3–4e7722098013

German:
https://www.DeutscheTageszeitung.de/wirtschaft/122111–josip–heit–gstelecom–g999–und–gsmedia–oder–die–fragen–nach–dem–potenzial–der–blockchain–f%C3%BCr–den–privatanwender.html

English:
https://www.DeutscheTageszeitung.de/wirtschaft/122112–josip–heit–gstelecom–g999–and–gsmedia–or–the–questions–about–the–potential–of–blockchain–for–private–users.html

The current products such as the GStelecom App for both Apple and Android can be downloaded here:
Google Play Store: https://play.google.com/store/apps/details?id=block.chain.chat
Apple Store: https://apps.apple.com/tt/app/gstelecom–by–g999–blockchain/id1547577247

META KEYS:
Josip Heit, GStelecom, GSmedia, G999, Josip Heit Chairman, Deutsche Tageszeitung, Blockchain, GSB Gold Standard Corporate, GSB Group, Alexandru Cocindau, Bitco World, G999 Blockchain technology, Blockchain, GStelecom Android, GStelecom Apple, GStelecom App

Legally responsible for this press release:
GSB Gold Standard Banking Corporation AG
Grosse Bleichen 35
D–20354 Hamburg
Register of the Hamburg Local Court, No: HRB 161409
Federal Republic of Germany

Press Department:
Mrs. Berger
Phone: +49 40 376 69 19 – 0
Fax: +49 40 376 69 89 – 3
Mail: Media@GSB.gold
Webpape: https://www.gsb.gold

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9c52e298–5775–414c–af8a–a3ad760c4f33


GLOBENEWSWIRE (Distribution ID 8227617)

Barrick Refers Senegalese Tax Dispute to Arbitration

All amounts expressed in US dollars

TORONTO, May 01, 2021 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) confirmed today that it had referred a tax claim by the Senegalese Revenue Authority (SRA) to the International Chamber of Commerce (ICC) for arbitration after numerous attempts to resolve the issue with the government had failed.

The SRA has levied an unaudited assessment totaling $208 million (calculated as of March 31, 2021) for taxes it claims arose from Barrick's sale of its interest in the Massawa project to Teranga Gold Corporation last year. Barrick said the proposed assessment was not in accordance with its investment agreement and relevant legislation in place, and in order to resolve the dispute, Barrick has referred the matter to the ICC which is the dispute resolution forum provided for in its agreement with the State of Senegal.

The arbitration process will start when the SRA has appointed its arbitrator. Barrick said in the meantime it would continue to engage with the government to resolve this matter. Barrick and its predecessor Randgold has been a partner and investor in the Senegalese mining industry since 1995, and continues to invest in its exploration projects, as well as through its investment in Endeavour Mining Corp.

Enquiries

President and CEO
Mark Bristow
+1 647 205 7694
+44 788 071 1386
Country Manager
Senegal
David Mbaye
+221 76 33 93 714
Investor and Media Relations
Kathy du Plessis
+44 20 7557 7738
Email: barrick@dpapr.com
Website: www.barrick.com

Cautionary Statement on Forward–Looking Information

Certain information contained in this press release, including any information as to Barrick's strategy, plans, or future financial or operating performance, constitutes "forward–looking statements". All statements, other than statements of historical fact, are forward–looking statements. The words "will", "would", "continue" and similar expressions identify forward–looking statements. In particular, this press release contains forward–looking statements including, without limitation, with respect to Barrick's strategy for the resolution of the Senegalese tax dispute through arbitration and continued engagement with the Senegalese Revenue Authority, and Barrick's continuing investment in exploration projects in Senegal.

Forward–looking statements are necessarily based upon a number of estimates and assumptions; including material estimates and assumptions related to the factors set forth below that, while considered reasonable by Barrick as at the date of this press release in light of management's experience and perception of current conditions and expected developments, are inherently subject to significant business, economic, and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward–looking statements, and undue reliance should not be placed on such statements and information. Such factors include, but are not limited to: timing of receipt of, or failure to comply with, necessary permits and approvals, including with respect to the assumption of closure obligations; the speculative nature of mineral exploration and development; changes in national and local government legislation, taxation, controls, or regulations and/or changes in the administration of laws, policies, and practices, expropriation or nationalization of property and political or economic developments in Senegal; lack of certainty with respect to foreign legal systems, corruption and other factors that are inconsistent with the rule of law; failure to comply with environmental and health and safety laws and regulations; litigation, arbitration and legal and administrative proceedings; risk of loss due to acts of war, terrorism, sabotage and civil disturbances; and damage to Barrick's reputation due to the actual or perceived occurrence of any number of events, including negative publicity with respect to the Barrick's handling of environmental matters or dealings with community groups, whether true or not. In addition, there are risks and hazards associated with the business of mineral exploration, development, and mining, including environmental hazards, industrial accidents, unusual or unexpected formations, pressures, cave–ins, flooding, and gold bullion, copper cathode, or gold or copper concentrate losses (and the risk of inadequate insurance, or inability to obtain insurance, to cover these risks).

Many of these uncertainties and contingencies can affect our actual results and could cause actual results to differ materially from those expressed or implied in any forward–looking statements made by, or on behalf of, us. Readers are cautioned that forward–looking statements are not guarantees of future performance. All of the forward–looking statements made in this press release are qualified by these cautionary statements.

Specific reference is made to the most recent Form 40–F/Annual Information Form on file with the SEC and Canadian provincial securities regulatory authorities for a more detailed discussion of some of the factors underlying forward–looking statements, and the risks that may affect Barrick's ability to achieve the expectations set forth in the forward–looking statements contained in this press release.

Barrick disclaims any intention or obligation to update or revise any forward–looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.


GLOBENEWSWIRE (Distribution ID 8227594)